Altimeter Capital’s Brad Gerstner criticizes AI negativity as political agenda

Brad Gerstner, CEO of Altimeter Capital, went on CNBC on September 11 and called the latest wave of AI doom warnings “hyperbolic scare tactics” motivated by a political agenda rather than legitimate safety science. His pushback came directly after a high-profile resignation at Anthropic reignited fears about superintelligence risk, and it arrived alongside a decidedly un-fearful portfolio move: nearly $590 million in fresh semiconductor positions.

What triggered the rant

The catalyst was Jacob Coxon, a researcher at Anthropic, who resigned and publicly stated that there is a significant risk of human extinction from advances in superintelligence. Coxon went further, claiming that many staff inside AI labs believe there is over a 10% chance of such an outcome within the next decade.

Gerstner’s response was blunt. He argued that AI developers are prioritizing safety more seriously than ever and that framing the technology as an existential threat serves a specific political purpose. He went so far as to suggest that some of the negative narratives around AI could be linked to foreign interests, specifically the Chinese Communist Party, aimed at slowing US innovation.

Gerstner positioned himself as favoring a middle path, dismissing both the “pause everything” camp and the “build without guardrails” crowd.

Follow the money: Qualcomm and Micron

Altimeter’s Q2 2026 filings revealed two major new positions. The firm invested approximately $347.9 million in Qualcomm, representing 3.54% of its reported US equity portfolio. It also put roughly $241.8 million into Micron Technology, accounting for 2.46% of the portfolio.

Beyond public equities, Altimeter maintains stakes in several private AI companies including Anthropic, OpenAI, Glean, and Databricks.

The bigger fight over AI regulation

Gerstner made this point explicitly, framing the negativity around AI as potentially serving CCP interests. The investment community has largely coalesced around a different narrative: that overregulation is the greater danger, particularly in the context of US-China competition. The argument goes that if Washington imposes heavy compliance burdens on American AI companies, Chinese firms operating under fewer constraints will capture market share in inference chips, model deployment, and the broader AI stack.

What this means for the AI investment landscape

The semiconductor angle is particularly telling. While much of the AI hype cycle has centered on model developers like OpenAI and Anthropic, the picks-and-shovels layer — the companies making the chips and memory that power everything — represents a more defensible investment thesis. These companies generate revenue whether a particular model succeeds or fails, as long as overall compute demand keeps rising.

Altimeter’s concentrated bets on Qualcomm and Micron suggest the firm expects that demand curve to steepen, not flatten, in the coming quarters. Dismissing a 10% extinction probability as a scare tactic is a bold call, and the market will eventually judge whether it was prescient or reckless.